All News

The use of Darzalex in combination with Revlimid, Velcade and Ozurdex demonstrated a higher percentage of stringent complete responses among transplant eligible, newly diagnosed patients with multiple myeloma.

The Food and Drug Administration granted CLR 131, a targeted, molecular radiotherapy, a fast track designation.

Breast cancer links to weight, diet and exercise are all over the news, but remember this: You are not to blame.

The Bladder Cancer Advocacy Network announced the recipient of its prestigious Bladder Cancer Research Innovation Award.

Don't sweat the small stuff, but don't miss those simple moments either.

An oncology dietitian offered advice on how to improve appetite and eat healthy before, during and after treatment for gastrointestinal cancers.

Moving on while letting go of being a 25-year-old caregiver back to being a young woman.

It is difficult to be patient, but cancer is a powerful teacher.

From today’s top performers and athletes to life-threatening social media disinformation, here’s what is making headlines in the cancer space this week.

Developing the skill of listening takes practice and for those with cancer, it's important to be heard. In this post, learn how one survivor helped others learn how to listen.

A quick scroll through the list of clinical trials made it clear I didn't know enough about my tumor and the mutations that made it unique.

The Food and Drug Administration has granted an accelerated approval to Xpovio in combination with dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma who have received more than four prior therapies.

Tumor mutation burden may be an independent predictor of developing depression in patients with lung cancer, according to Dr. Daniel McFarland.

These weekly recipes, created by oncology dieticians from the John Theurer Cancer Center, offer benefits to those living with cancer and going through treatment.

Cancer can bring about post-traumatic stress disorder that can linger for many years in both survivors of childhood cancer and their parents.

Many patients wonder why their chemotherapy infusions take so long, so three health care professionals explained the process from start to finish.

Living with cancer means more than letting the negative go, it means finding a way to take in the happiness of right now. This cancer survivor calls it "Minute Mindfulness."

Blue Faery provides patients with hepatocellular carcinoma and their caregivers a range of focused resources. The goal of Blue Faery’s patient community is to improve the quality of life for patients, support their caregivers and give them hope, information and a voice.

Doing a self-assessment, identifying opportunities/obstacles and creating an action plan will help cancer survivors to transition into a new profession, according to one career coach.

Are these new health conditions popping up late effects from the drugs used in my previous cancer treatment? We are only now living long enough after treatment for the doctors to see what happens years later.

This survivor shares the benefits of finding a local cancer support group or individual as she laments the retirement of her own cancer support group leader.

Here are the top 5 CURE stories for June 2019.

Asking an employer to modify a work space or schedule may help patients adjust to returning to work during cancer treatment.

My doctor explained to me I was in what is called “partial remission.” I am well aware that this is temporary, but as I wrote in another article – so is life! While there is no cure for my disease, I choose to appreciate each and every day that I feel good.

Breast cancer affects both men and women, yet there continues to be a "separation of power" when it comes to research and development of the methods by which to treat breast cancer. I think the greatest hope for men to come out of the shadow of breast cancer in a very pink world is through the support of women.

From Beth Chapman’s untimely passing to cancer fundraising via esports, here’s what is making headlines in the cancer space this week.

The FDA has approved Zirabev, a biosimilar to Avastin, for the treatment of five types of cancer: colorectal cancer; non-small cell lung cancer; glioblastoma; metastatic renal cell carcinoma; and persistent, recurrent or metastatic cervical cancer.

The FDA has approved the combination of Darzalex with Revlimid and dexamethasone (DRd) for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation.